Drucken
Artikel, Notizen und Markierungen werden geladen... Bitte um etwas Geduld.

Radiological Protection Ordinance
(RPO)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 26 April 2017 (Status as of 1 January 2022)

Art. 123 Design of enterprises

1 The li­cence hold­er must ad­opt ap­pro­pri­ate meas­ures to pre­vent fail­ures.

2 The en­ter­prise must be de­signed in such a way that the fol­low­ing re­quire­ments are met:

a.
For fail­ures with an ex­pec­ted fre­quency of more than 10-1 per year, it must be pos­sible for the source-re­lated dose con­straints spe­cified in the li­cence to be com­plied with.
b.
For fail­ures with an ex­pec­ted fre­quency of between 10–1 and 10–2 per year, a single such event must not lead to an ad­di­tion­al dose which ex­ceeds the rel­ev­ant source-re­lated dose con­straints.
c.
For fail­ures with an ex­pec­ted fre­quency of between 10-2 and 10-4 per year, the dose res­ult­ing from a single such event for mem­bers of the pub­lic must not be great­er than 1 mSv.
d.
For fail­ures with an ex­pec­ted fre­quency of between 10-4 and 10-6 per year, the dose res­ult­ing from a single such event for mem­bers of the pub­lic must not be great­er than 100 mSv; the li­cens­ing au­thor­ity may spe­cify a lower dose in in­di­vidu­al cases.

3 The en­ter­prise must be de­signed in such a way that only a small num­ber of fail­ures as spe­cified in para­graph 2 let­ters c or d can oc­cur.

4 For fail­ures as spe­cified in para­graph 2 let­ters c and d and for fail­ures which have an ex­pec­ted fre­quency of less than 10-6 per year, but which could have ma­jor im­pacts, the su­per­vis­ory au­thor­ity shall re­quire the en­ter­prise to ad­opt the ne­ces­sary pre­pared­ness meas­ures.

5 The su­per­vis­ory au­thor­ity shall spe­cify on a case-by-case basis the meth­od­o­logy and bound­ary con­di­tions for the ana­lys­is of fail­ures and for their as­sign­ment to the fre­quency classes spe­cified in para­graph 2 let­ters b–d. The ef­fect­ive dose or the equi­val­ent doses arising from fail­ure-re­lated ex­pos­ure of per­sons must be de­term­ined in ac­cord­ance with the cur­rent state of sci­ence and tech­no­logy, us­ing the as­sess­ment quant­it­ies and dose coef­fi­cients spe­cified in An­nexes 3, 5 and 6.

6 For en­ter­prises where fail­ures as spe­cified in para­graph 2 let­ter d may oc­cur, the su­per­vis­ory au­thor­ity may or­der:

a.
the meas­ure­ment of in­stall­a­tion para­met­ers which are re­quired to mon­it­or the course of an ac­ci­dent, to pro­duce dia­gnoses and fore­casts, and to de­term­ine the meas­ures ne­ces­sary to pro­tect the pub­lic;
b.
the con­tinu­ous trans­mis­sion of the in­stall­a­tion para­met­ers to the su­per­vis­ory au­thor­it­ies via a net­work tol­er­ant of an fail­ure.